Sector: Pharmaceuticals & Biotechnology

Small Cap

Beta Drugs Share Price

Beta Drugs Ltd.

₹2,069

-95.40(-4.41%)

25th Jun 2026 | 3:28 PM

NSE : BETA

Open Free Demat Account

Beta Drugs Performance

Price Movement

₹2069.00

₹2050.00

₹2189.80

↘ Today's Low↗ Today's High

1 Year Performance

₹2069.00

₹990.10

₹2250.00

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹2,189.80

Low₹2,050.00

Open at₹2,164.40

Prev Close₹2,164.40

Volumes15.99 K

Avg Price₹2,123.67

Lower Circuit₹1,731.60

Upper Circuit₹2,597.20

Historical Performance

3M High₹2,250.00

3M Low₹1,055.10

1 Yr High₹2,250.00

1 Yr Low₹990.10

3 Yr High₹2,250.00

3 Yr Low₹693.33

5 Yr High₹2,250.00

5 Yr Low₹270.57

Summary

As of 26-06-2026 03:12, Beta Drugs Ltd. share price today is ₹0, with a change of ₹-2164.40 (-100.00%) from the previous close of ₹2164.4. The stock opened at ₹2164.4 and traded between ₹2050 and ₹2189.8, with a total traded volume of 15986 shares. The company has a market capitalization of ₹2175.9 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹2250 and ₹990.1, respectively.

Beta Drugs Ltd. valuation metrics include a P/E ratio of 52.5, EPS of ₹40.92, and book value of ₹8.90. Profitability indicators show ROE of 16.94%. Beta Drugs Ltd. has reported revenue of ₹384.83 Cr and net profit of ₹41.48 Cr.

Beta Drugs Ltd. technical indicators include Day RSI at 80.85, Day MFI at 88.21, Day ADX at 41.41. Additional indicators include Commodity Channel Index (CCI) at 124.3 and Williams %R at -10.13. Momentum indicators show Day MACD at 196.83, Day MACD Signal Line at 143.21, DayATR at 118.85. Rate of Change indicators for Beta Drugs Ltd. include ROC125 at 39.69 and ROC21 at 58.14.

Exponential moving averages include EMA5 at ₹2064.4, EMA10 at ₹1936.8, EMA12 at ₹1893.7, EMA20 at ₹1763.5, EMA26 at ₹1696.8, EMA50 at ₹1551.7, EMA100 at ₹1479, EMA200 at ₹1510.5. Simple moving averages include SMA5 at ₹2068.7, SMA10 at ₹1918.8, SMA20 at ₹1687.4, SMA30 at ₹1561.6, SMA50 at ₹1473.2, SMA100 at ₹1353.3, SMA150 at ₹1438.7, SMA200 at ₹1529.5.

Support levels for Beta Drugs are placed at First Support ₹2100.07, Second Support ₹2035.73, Third Support ₹1978.27. Resistance levels are seen at First Resistance ₹2221.87, Second Resistance ₹2279.33, Third Resistance ₹2343.67. Beta Drugs Ltd. shareholding pattern shows promoter holding at 64.63%, FII holding at 1.16%, DII holding at 0%, public holding at 32.05%.

Beta Drugs Fundamentals

Market Cap

Above industry Median

2,175.90 Cr.

PE Ratio (TTM)

High in industry

52.50

Dividend Yield

Net Profit TTM

41.48

Net Profit Growth

41.48

PEG Ratio

ROE

21% decr over last year

16.94

Operating Revenue TTM

384.83

Operating Revenue Growth

Book Value

High in industry

8.90

MFI

MFI strongly Overbought

88.21

RSI

RSI strongly Overbought

80.85

EPS (TTM)

40.92

Debt to Equity

0.60

Face Value

Operating Profit Margin Qtr.

19.11

Operating Profit Qtr.

17.68

Net Profit Qtr.

9.05

Operating Revenue Qtr.

93.96

PB Ratio

8.90

Beta Drugs Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Revenue	54.35	50.28	54.48	66.32	53.74
Operating Expense	44.59	43.73	49.75	58.82	48.49
Operating Profit	9.76	6.55	4.73	7.51	5.25
Depreciation	2.74	2.51	2.38	2.04	2.14
Interest	2.87	3.17	2.97	2.79	2.81
Tax	1.73	0.12	0.61	1.42	0.62
Net Profit	5.33	3.25	1.51	4.23	1.39

Beta Drugs Technicals

Beta Drugs Ltd. EMA & SMA

₹2069.00

-95.40 (-4.41%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹2064.4

Day EMA10 ₹1936.8

Day EMA12 ₹1893.7

Day EMA20 ₹1763.5

Day EMA26 ₹1696.8

Day EMA50 ₹1551.7

Day EMA100 ₹1479

Day EMA200 ₹1510.5

Beta Drugs Support and Resistance

Resistance

First Resistance₹2221.87

Second Resistance₹2279.33

Third Resistance₹2343.67

Support

First Support₹2100.07

Second Support₹2035.73

Third Support₹1978.27

Technical Indicators

Day RSI80.85

Day MFI88.21

Day ADX41.41

Day Commodity Channel Index124.30

William-10.13

Day MACD196.83

Day MACD Signal Line143.21

Day ATR118.85

Day ROC12539.69

Day ROC2158.14

Beta Drugs Shareholding Pattern

Held By	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Promoter	66.7	66.7	66.7	66.7	64.9	64.6
FII	1.2	0.9	0.9	0.9	1.1	1.2
DII	0.1	0.2	0.3	0.3	1.9	2.1
Public	31.9	32.2	32.1	32.1	32.1	32

Beta Drugs Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	12.07 K	31.11 K	38.79%
Week	24.22 K	62.63 K	38.67%
1 Month	16.68 K	46.85 K	35.60%
6 Month	9.17 K	19.63 K	46.70%

Beta Drugs SWOT Analysis

Strengths18

Weakness15

Opportunity1

Threats0

Benjamin Graham Value Screen

Companies with 10% increase in share price over three months, with rising net profit growth

Strong Momentum: Price above short, medium and long term moving averages

Consistent high performing stocks over Five Years

Expensive Rockets (DVM)

Relative Outperformance versus Industry over 1 Month

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Overbought by Money Flow Index (MFI)

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

Near 52 Week High

Stock gained more than 20% in one month

Negative to Positive growth in Sales and Profit with Strong Price momentum

Highest Recovery from 52 Week Low

Stocks Outperforming their Industry Price Change in the Quarter

Beta Drugs Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
No Record Found

Beta Drugs Stock Comparison

Financials	Bio Medica Laboratories Ltd.	Sai Parenterals Ltd.	Vivimed Labs Ltd.	Curis Lifesciences Ltd.	Amanta Healthcare Ltd.	Anlon Healthcare Ltd.
Price (₹)	₹141.10	₹588	₹5.70	₹102	₹162	₹16.37
% Change	-1.60%	-0.30%	-1.04%	-1.92%	-0.52%	1.49%
Revenue TTM (₹ Cr)	-	-	₹83.60	-	₹287.68	₹176.50
Net Profit TTM (₹ Cr)	-	-	₹-34.95	-	₹14.88	₹27.81
PE TTM	68.90	-	-1.40	11.90	41.90	31.10
1 Year Return	3.67	49.31	471	-20.31	27.52	79.01
ROCE	-	3.56	-5.63	-	-	17.36

Similar Stocks

MEDISTEP

Medistep Healthcare Ltd.

₹ 19.90

-5.24%

INFLUX

Influx Healthtech Ltd.

₹ 286.00

+9.87%

MEDIORG

Medicamen Organics Ltd.

₹ 23.75

-5.00%

AMRUTANJAN

Amrutanjan Health Care Ltd.

₹ 536.00

+0.07%

VALIANTLAB

Valiant Laboratories Ltd.

₹ 68.00

-0.06%

SIGACHI

Sigachi Industries Ltd.

₹ 24.80

-1.98%

WINDLAS

Windlas Biotech Ltd.

₹ 855.00

-1.02%

VINEETLAB

Vineet Laboratories Ltd.

₹ 33.86

-0.24%

SOLARA

Solara Active Pharma Sciences Ltd.

₹ 569.90

-0.42%

ZIMLAB

Zim Laboratories Ltd.

₹ 127.00

-0.68%

MEDICO

Medico Remedies Ltd.

₹ 40.00

-2.56%

DCAL

Dishman Carbogen Amcis Ltd.

₹ 170.70

-2.02%

LASA

Lasa Supergenerics Ltd.

₹ 7.68

+0.26%

ADVENZYMES

Advanced Enzyme Technologies Ltd.

₹ 346.90

-6.01%

BAJAJHCARE

Bajaj Healthcare Ltd.

₹ 305.80

-1.61%

ORTINGLOBE

Ortin Global Ltd.

₹ 17.43

+0.98%

BROOKS

Brooks Laboratories Ltd.

₹ 73.20

-4.69%

RPGLIFE

RPG Life Sciences Ltd.

₹ 2275.00

-0.60%

BAFNAPH

Bafna Pharmaceuticals Ltd.

₹ 194.68

+5.00%

ALPA

Alpa Laboratories Ltd.

₹ 68.50

-0.35%

SMSPHARMA

SMS Pharmaceuticals Ltd.

₹ 376.65

-0.49%

NECLIFE

Nectar Lifesciences Ltd.

₹ 11.48

-0.52%

MANGALAM

Mangalam Drugs and Organics Ltd.

₹ 28.75

-1.10%

INDOCO

Indoco Remedies Ltd.

₹ 231.00

-2.61%

FAQ's on BETA

What is the Market Capitalization of Beta Drugs Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Beta Drugs Ltd. is approximately ₹ 2175.9 Cr.

What are the PE and PB ratios for Beta Drugs Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Beta Drugs Ltd. is 52.5, and the Price-to-Book (PB) ratio is 8.9.

What is the 52-Week High and Low for Beta Drugs Ltd.?

Over the past 52 weeks, the highest price reached by Beta Drugs Ltd. shares was ₹ 2250, and the lowest price was ₹ 990.1.

Who are the major shareholders of Beta Drugs Ltd.?

Significant shareholdings in Beta Drugs Ltd. typically include entities such as:

Promoter
Public
Other Institutions
FII

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Beta Drugs Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Beta Drugs Ltd. is often compared with other major players such as Bio Medica Laboratories, Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda and Rekvina Laboratories for analysis and benchmarking.